137 related articles for article (PubMed ID: 19021561)
1. Towards a Drosophila model of Hutchinson-Gilford progeria syndrome.
Beard GS; Bridger JM; Kill IR; Tree DR
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1389-92. PubMed ID: 19021561
[TBL] [Abstract][Full Text] [Related]
2. Sulforaphane enhances progerin clearance in Hutchinson-Gilford progeria fibroblasts.
Gabriel D; Roedl D; Gordon LB; Djabali K
Aging Cell; 2015 Feb; 14(1):78-91. PubMed ID: 25510262
[TBL] [Abstract][Full Text] [Related]
3. A lamin A protein isoform overexpressed in Hutchinson-Gilford progeria syndrome interferes with mitosis in progeria and normal cells.
Cao K; Capell BC; Erdos MR; Djabali K; Collins FS
Proc Natl Acad Sci U S A; 2007 Mar; 104(12):4949-54. PubMed ID: 17360355
[TBL] [Abstract][Full Text] [Related]
4. In vivo base editing rescues Hutchinson-Gilford progeria syndrome in mice.
Koblan LW; Erdos MR; Wilson C; Cabral WA; Levy JM; Xiong ZM; Tavarez UL; Davison LM; Gete YG; Mao X; Newby GA; Doherty SP; Narisu N; Sheng Q; Krilow C; Lin CY; Gordon LB; Cao K; Collins FS; Brown JD; Liu DR
Nature; 2021 Jan; 589(7843):608-614. PubMed ID: 33408413
[TBL] [Abstract][Full Text] [Related]
5. Lamin A, farnesylation and aging.
Reddy S; Comai L
Exp Cell Res; 2012 Jan; 318(1):1-7. PubMed ID: 21871450
[TBL] [Abstract][Full Text] [Related]
6. Identification of differential protein interactors of lamin A and progerin.
Kubben N; Voncken JW; Demmers J; Calis C; van Almen G; Pinto Y; Misteli T
Nucleus; 2010; 1(6):513-25. PubMed ID: 21327095
[TBL] [Abstract][Full Text] [Related]
7. Permanent farnesylation of lamin A mutants linked to progeria impairs its phosphorylation at serine 22 during interphase.
Moiseeva O; Lopes-Paciencia S; Huot G; Lessard F; Ferbeyre G
Aging (Albany NY); 2016 Feb; 8(2):366-81. PubMed ID: 26922519
[TBL] [Abstract][Full Text] [Related]
8. Long lifetime and tissue-specific accumulation of lamin A/C in Hutchinson-Gilford progeria syndrome.
Hasper J; Welle K; Swovick K; Hryhorenko J; Ghaemmaghami S; Buchwalter A
J Cell Biol; 2024 Jan; 223(1):. PubMed ID: 37966721
[TBL] [Abstract][Full Text] [Related]
9. Genetic and pharmacological modulation of lamin A farnesylation determines its function and turnover.
Foo MXR; Ong PF; Yap ZX; Maric M; Bong CJS; Dröge P; Burke B; Dreesen O
Aging Cell; 2024 May; 23(5):e14105. PubMed ID: 38504487
[TBL] [Abstract][Full Text] [Related]
10. Generation of a Hutchinson-Gilford progeria syndrome monkey model by base editing.
Wang F; Zhang W; Yang Q; Kang Y; Fan Y; Wei J; Liu Z; Dai S; Li H; Li Z; Xu L; Chu C; Qu J; Si C; Ji W; Liu GH; Long C; Niu Y
Protein Cell; 2020 Nov; 11(11):809-824. PubMed ID: 32729022
[TBL] [Abstract][Full Text] [Related]
11. Heterochromatin loss as a determinant of progerin-induced DNA damage in Hutchinson-Gilford Progeria.
Chojnowski A; Ong PF; Foo MXR; Liebl D; Hor LP; Stewart CL; Dreesen O
Aging Cell; 2020 Mar; 19(3):e13108. PubMed ID: 32087607
[TBL] [Abstract][Full Text] [Related]
12. Exacerbated atherosclerosis in progeria is prevented by progerin elimination in vascular smooth muscle cells but not endothelial cells.
Benedicto I; Carmona RM; Barettino A; Espinós-Estévez C; Gonzalo P; Nevado RM; de la Fuente-Pérez M; Andrés-Manzano MJ; González-Gómez C; Rolas L; Dorado B; Nourshargh S; Hamczyk MR; Andrés V
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2400752121. PubMed ID: 38648484
[TBL] [Abstract][Full Text] [Related]
13. A high-content imaging-based screening pipeline for the systematic identification of anti-progeroid compounds.
Kubben N; Brimacombe KR; Donegan M; Li Z; Misteli T
Methods; 2016 Mar; 96():46-58. PubMed ID: 26341717
[TBL] [Abstract][Full Text] [Related]
14. iPSC-Derived Endothelial Cells Affect Vascular Function in a Tissue-Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome.
Atchison L; Abutaleb NO; Snyder-Mounts E; Gete Y; Ladha A; Ribar T; Cao K; Truskey GA
Stem Cell Reports; 2020 Feb; 14(2):325-337. PubMed ID: 32032552
[TBL] [Abstract][Full Text] [Related]
15. Development of an accelerated cellular model for early changes in Alzheimer's disease.
Xue H; Gate S; Gentry E; Losert W; Cao K
Sci Rep; 2023 Oct; 13(1):18384. PubMed ID: 37884611
[TBL] [Abstract][Full Text] [Related]
16. DNA-damage accumulation and replicative arrest in Hutchinson-Gilford progeria syndrome.
Musich PR; Zou Y
Biochem Soc Trans; 2011 Dec; 39(6):1764-9. PubMed ID: 22103522
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular pathology in Hutchinson-Gilford progeria: correlation with the vascular pathology of aging.
Olive M; Harten I; Mitchell R; Beers JK; Djabali K; Cao K; Erdos MR; Blair C; Funke B; Smoot L; Gerhard-Herman M; Machan JT; Kutys R; Virmani R; Collins FS; Wight TN; Nabel EG; Gordon LB
Arterioscler Thromb Vasc Biol; 2010 Nov; 30(11):2301-9. PubMed ID: 20798379
[TBL] [Abstract][Full Text] [Related]
18. Depleting the methyltransferase Suv39h1 improves DNA repair and extends lifespan in a progeria mouse model.
Liu B; Wang Z; Zhang L; Ghosh S; Zheng H; Zhou Z
Nat Commun; 2013; 4():1868. PubMed ID: 23695662
[TBL] [Abstract][Full Text] [Related]
19. Expression of progerin in aging mouse brains reveals structural nuclear abnormalities without detectible significant alterations in gene expression, hippocampal stem cells or behavior.
Baek JH; Schmidt E; Viceconte N; Strandgren C; Pernold K; Richard TJ; Van Leeuwen FW; Dantuma NP; Damberg P; Hultenby K; Ulfhake B; Mugnaini E; Rozell B; Eriksson M
Hum Mol Genet; 2015 Mar; 24(5):1305-21. PubMed ID: 25343989
[TBL] [Abstract][Full Text] [Related]
20. Systematic screening identifies therapeutic antisense oligonucleotides for Hutchinson-Gilford progeria syndrome.
Puttaraju M; Jackson M; Klein S; Shilo A; Bennett CF; Gordon L; Rigo F; Misteli T
Nat Med; 2021 Mar; 27(3):526-535. PubMed ID: 33707772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
